Nav: Home

Current Hepatitis News and Events | Page 2

Current Hepatitis News and Events, Hepatitis News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
New hepatitis C cases down by almost 70 percent in HIV-positive men in London
New cases of hepatitis C amongst HIV-positive men in London have fallen by nearly 70 percent in recent years. (2019-03-06)
A silver lining like no other
New technology from the University of South Australia is revolutionizing safe vaccination practices through antibacterial, silver-loaded dissolvable microneedle patches, which not only sterilize the injection site to inhibit the growth of bacteria, but also physically dissolve after administration. (2019-03-05)
Penn team eradicates Hepatitis C in patients after heart transplants from infected donors
Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American Journal of Transplantation. (2019-02-25)
Common virus is 'less prone to mutation' giving hope for vaccine development
One of the commonest causes of congenital disability, the Human Cytomegalovirus (HCMV), is less prone to mutation than previously thought, a finding which could help develop a successful vaccine, UCL researchers have found. (2019-02-25)
Do we have an epidemic? Enhancing disease surveillance using a health information exchange
While disease surveillance has shifted toward greater use of electronically transmitted information to decrease the reporting burden on physicians, the challenge of getting the right information to public health officials at the right time has not been completely solved. (2019-02-11)
The Lancet: Direct-acting antivirals reduce risk of premature mortality and liver cancer for people with chronic hepatitis C
The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer, according to a study published in The Lancet. (2019-02-11)
A new protocol for Hepatitis A vaccination to prevent a vaccine-resistant virus
Researchers of the University of Barcelona (UB) have analysed, with massive sequencing techniques for the first time, the evolution of the Hepatitis A virus with samples from patients. (2019-02-08)
OxyContin reformulation to curb opioid abuse led to hepatitis C surge, study finds
Public health officials have blamed the shift from prescription opioids to injectable heroin as a cause of the rise in hepatitis C cases. (2019-02-04)
The Lancet: Major progress against hepatitis C by 2030 is possible, but will need vast improvements in screening, prevention and treatment
A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally published in The Lancet. (2019-01-28)
Needle and syringe programs cost-effectively prevent hepatitis C transmission
Providing clean injecting equipment through needle and syringe programs is a highly cost-effective way of preventing hepatitis C (HCV) transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to research led by the University of Bristol and London School of Hygiene & Tropical Medicine. (2019-01-23)
Liver transplants double for alcohol-related liver disease
The proportion of US liver transplants for alcohol-associated liver disease (ALD) has doubled in the last 15 years, in part due to broader acceptance of waiving the mandated period of sobriety before transplants for this population, according to a study by researchers at UC San Francisco, which showed ongoing regional geographic variations in liver transplant rates for ALD patients, whose long-term survival rate is slightly lower than other liver transplant patients. (2019-01-22)
Liver transplant for alcohol-related liver disease in US
The proportion of liver transplants in the United States for alcohol-associated liver disease increased between 2002 and 2016, with much of the increase associated with a decrease in liver transplant for hepatitis C virus infection because of antiviral therapy. (2019-01-22)
Liver cancer patients can be treated for Hep C infection
A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer. (2019-01-18)
Many hepatitis infections go undiagnosed in cancer patients
Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. (2019-01-17)
How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases. (2018-12-21)
Himalayan marmot genome offers clues to life at extremely high altitudes
Himalayan marmots can survive at altitudes up to 5,000 meters in the Himalayan regions of India, Nepal, and Pakistan and on the Qinghai-Tibetan Plateau of China, where many of them face extreme cold, little oxygen, and few other resources. (2018-12-20)
Hepatitis: Liver failure attributable to compromised blood supply
In severe cases, a viral hepatitis infection can result in liver failure. (2018-12-19)
Sofosbuvir rids organism of chikungunya and yellow fever viruses
Sofosbuvir is already used to treat hepatitis C and has passed all human use approval tests, so it can be fairly easily deployed if the chikungunya epidemic forecast for the next two years materializes. (2018-12-18)
New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa. (2018-12-17)
RUDN medics called the world to action against hepatitis in Somalia
Using mathematical statistics methods, RUDN medics analyzed the data of 30 studies of the cases of hepatitis in Somalia. (2018-12-12)
Newly identified T cells could play a role in cancer and other diseases
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute for Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the molecules that help form cells' outer membranes. (2018-12-05)
Genetic relic of the 'black death' may offer clues in treating liver disease
A gene mutation that is believed to have safeguarded some people in 14th century Europe from the bubonic plague today may be protecting HIV patients co-infected with hepatitis C from potentially fatal liver scarring, says a University of Cincinnati (UC) College of Medicine physician-scientist. (2018-12-03)
Ending the HIV epidemic: Where does Europe stand?
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. (2018-11-29)
State lawmakers want to loosen childhood vaccine requirements, but legal barriers persist
An analysis of proposed vaccine legislation between 2011 and 2017 shows that although the majority of proposed bills would have allowed more parents to exempt their children from school immunization requirements, those that favored vaccines were more likely to become law. (2018-11-29)
ECDC issues integrated hepatitis and HIV testing Guidance
Targeted testing to reach those most at-risk of infection is an essential element of any strategy to eliminate viral hepatitis and HIV across the countries in the European Union and European Economic Area (EU/EEA). (2018-11-23)
Targeted Hepatitis C testing misses substantial number of cases in correctional setting
Results from a new study led by Boston Medical Center (BMC) found routine Hepatitis C testing identified a significant number of cases that would have been missed by targeted testing among a population of individuals in Washington State prisons (2018-11-19)
Screening for hepatitis B and C: Benefit unclear due to a lack of suitable studies
There are no suitable studies for the benefit assessment of screenings of the general population. (2018-11-14)
NIH scientists illuminate causes of hepatitis b virus-associated acute liver failure
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF) -- a rare condition that can turn fatal within days without liver transplantation -- results from an uncommon encounter between a highly mutated HBV variant and an unusual immune response in the patient's liver that is mainly sustained by antibody-producing B cells. (2018-11-13)
Hepatitis C treatment can be shortened in 50 percent of patients, study finds
Hepatitis C drugs cure more than 90 percent of patients, but can cost more than $50,000 per patient. (2018-11-12)
Caution, tasteless! Viruses and antimicrobially resistant bacteria in foods
Salmonella in eggs, noroviruses in frozen berries, hepatitis E viruses in domestic pigs and wild boar and resistant bacteria in meat: pathogenic microorganisms are one of the most common causes of foodborne illnesses. (2018-11-08)
High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months. (2018-10-30)
Donor hearts at increased disease risk offer better survival rates for transplant recipients
Accepting an organ that has an increased risk of potentially transmitting disease offers a higher one-year survival rate for candidates on the heart transplant list over waiting for an organ with less risk, according to a study published today in the Journal of the American College of Cardiology. (2018-10-29)
Interleukin IL-22, a new target to inhibit the progression of liver disease
Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease. (2018-10-26)
UC researchers recommend universal screening to tackle rise in Hepatitis C
Physicians are encountering a growing number of younger patients who are testing positive for hepatitis C virus (HCV) fueled largely by the opioid crisis impacting communities around the country. (2018-10-17)
Genetic Achilles heel hurts humans fighting hepatitis C
An antimicrobial signaling molecule called IFNλ4 has lower activity against the hepatitis C virus in the vast majority of humans compared with chimpanzees and African hunter-gatherer Pygmies, according to a study published Oct. (2018-10-11)
At-risk teens and young adults overlooked during opioid crisis
Teens and young adults who have injected drugs are at risk for contracting hepatitis C, but most aren't tested and therefore don't receive life-saving treatment, according to a national study being presented at IDWeek 2018. (2018-10-04)
Overwhelming evidence shows hepatitis C treatment effective for people who inject drugs
Researchers are calling on an end to discriminatory health and illicit drugs policies, based on overwhelming evidence that new hepatitis C therapies are effective at curing the virus in people who inject drugs. (2018-09-20)
Mongrel Mob open up to Otago researchers for the good of their health
Studying the liver health of a high-risk, hard-to-reach gang population certainly came with challenges and a few surprises, a University of Otago academic says. (2018-08-29)
New target could prevent progression of liver damage to cancer
Problems like obesity and alcoholism appear to chronically trigger in the liver a receptor known to amplify inflammation in response to invaders like bacteria, scientists report. (2018-08-27)
Study reports successful kidney transplants from donors with a history of hepatitis C
Researchers at Loma Linda University Health found that kidney transplantation can be safely performed using organs testing positive for the hepatitis C virus (HCV) antibody but negative for active viral infection. (2018-08-22)
Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...